Apimeds Pharmaceuticals US, Inc. (APUS)
4.55
-0.07
(-1.52%)
USD |
NYAM |
Oct 14, 10:54
Apimeds Pharmaceuticals US Total Assets (Quarterly) : 127.62M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 127.62M |
| March 31, 2026 | 141.22M |
| December 31, 2025 | 164.18M |
| September 30, 2025 | 9.25M |
| June 30, 2025 | 10.55M |
| March 31, 2025 | 0.2599M |
| Date | Value |
|---|---|
| December 31, 2024 | 0.0131M |
| September 30, 2024 | 0.0369M |
| June 30, 2024 | 0.0737M |
| March 31, 2024 | 0.1577M |
| December 31, 2023 | 0.4221M |
| September 30, 2023 | 0.9227M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.18M |
| Shareholders Equity (Quarterly) | 106.45M |
| Debt to Equity Ratio | 0.1369 |
| Current Ratio | 0.5067 |
| Net Debt Paydown Yield | -20.17% |